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 
Abstract— In recent years, our group has developed a 
comprehensive cardiopulmonary (CP) model that comprises 
the heart, systemic and pulmonary circulations, lung mechanics 
and gas exchange, tissue metabolism, and cardiovascular and 
respiratory control mechanisms. In this paper, we analyze the 
response of the model to hypercapnic conditions and hence 
focus on the chemoreflex control mechanism. Particularly, we 
have enhanced the peripheral chemoreceptor model in order to 
better reflect respiratory control physiology. Using the CO2 
fraction in the inspired air as input to the CP model, we were 
able to analyze the transient response of the system to CO2 step 
input at different levels, in terms of alveolar gas partial 
pressures, tidal volume, minute ventilation and respiratory 
frequency. Model predictions were tested against experimental 
data from human subjects [1]. Results show good agreement 
for all the variables under study during the transient phases 
and low root mean square errors at steady state. This indicates 
the potential for the model to be used as a valid tool for clinical 
practice and medical research, providing a complementary way 
to experience-based clinical decisions. 
I. INTRODUCTION 
IMULATIONS of hypercapnia by means of a comprehensive 
cardiopulmonary model offer useful information from 
physiological and clinical perspectives. First, the complex 
interactions between the cardiovascular and respiratory systems 
can be analyzed and understood; the individual components of 
the physiological control mechanisms of cardio-pulmonary 
regulation can be evaluated; and, the overall response of the 
system can be studied in a more rigorous and quantitative 
manner. Further, hypercapnic respiratory failure (usually 
hypoventilation-induced) is very commonly observed in 
intensive care unit (ICU) patients suffering, for instance, from 
chronic obstructive pulmonary disease (COPD), sleep apnea, 
obesity hypoventilation syndrome, and others. Having a model 
that is able to emulate the patient and predict the response to 
different levels of inspired gas fractions could be a valuable tool 
to provide clinical decision supportive information in the ICU. 
II. METHODS 
The cardiopulmonary model includes description of the 
cardiovascular system, lung mechanics, gas exchange in the 
alveoli and tissue metabolism along with the main control 
mechanisms involved in cardiopulmonary regulation. 
 
Manuscript received April 15, 2011.  
A. Albanese is with the Department of Biomedical Engineering, 
Columbia University, New York, NY 10027 (e-mail: 
aa2932@columbia.edu).  
N. W. Chbat is with Philips Research North America. Briarcliff Manor, 
NY 10510; Corresponding author phone: 914-945-6238; e-mail: 
chbat@philips.com. 
M. Ursino is with the Department of Electronics, Computer Science and 
Systems, University of Bologna, Bologna, 40136 Italy (e-mail: 
mauro.ursino@unibo.it). 
Particularly, cardiovascular control is mediated by 
baroreceptors, lung stretch receptors, peripheral chemorecptors, 
local autoregulation and a direct effect of the central nervous 
system (CNS ischemic response), whereas respiratory control is 
mediated by central and peripheral chemorecptors. Description 
of the model has been provided in [2]. For this reason, only a 
quick overview of the model is described next, with an 
emphasis on the new aspects of the chemoreflex mechanism 
and related hypercapnic simulations. 
A. Cardiovascular Model 
The cardiovascular model has been adapted from previous 
work [3], [4]. It includes pulsatile description of the right and 
left hearts, as well as systemic and pulmonary circulations. 
Cardiovascular function is assumed under the control of the 
autonomic nervous system and local metabolic mechanisms 
(autoregulation). Details on the model can be found in [3], [4].  
B. Lung Mechanics and Gas Exchange Models 
The lung mechanics dynamic model has been adapted from 
an existing model [5]. It includes 4 compartments: larynx, 
trachea, bronchea and alveoli. As shown in Fig. 1, each 
compartment is represented as combination of a linear 
compliance and a linear resistance. The model can be driven by 
two different pressure source generators: a thoracic source Ut, 
which mimics the action of the respiratory muscles, and an 
external source Um, which mimics the effect of a mechanical 
ventilator. The two sources can be separately switched on to 
simulate either spontaneous breathing or artificial ventilation, 
but they can also act at the same time to simulate simultaneous 
natural and artificial breathing condition (assisted ventilation).  
 
Fig. 1.  Electrical analog of the lung mechanics system. C:capacitance, 
R:resistance. Subscripts: m:mouth, l:larynx, t:trachea, b:bronchi, A:alveoli 
 
The thoracic pressure generator Ut is modeled as a sinusoidal 
function of amplitude At and frequency ft, with a negative bias 
term to account for longer exhalation time: 
BtfAU ttt  )2sin(               (1) 
The gas exchange model includes dead space, alveoli and 
pulmonary capillaries. Equations governing the model are 
derived based on conservation of mass using gas fractions in the 
inspired air as inputs. Oxygen and carbon dioxide metabolic 
processes at the tissue level are also described by way of 
differential equations based on mass conservation, assuming 
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that O2 and CO2 metabolic rates are constant and known. 
Finally, pulmonary shunts, transport circulatory delays and 
empirical dissociation curves [6] are also included in the model. 
C. Respiratory Control Model 
The automatic control of breathing in humans involves central 
and peripheral chemoreceptors that increase pulmonary 
ventilation when stimulated. Inputs to the chemoreflex are the 
cellular hydrogen ion concentrations at both central and 
peripheral sites, often expressed in terms of partial pressure of 
oxygen and carbon dioxide in the blood. Particularly, peripheral 
chemoreceptors are sensitive to both PaO2 and PaCO2, whereas 
central chemoreceptors are sensitive to PaCO2 only. In addition, 
respiration is driven by an intrinsic respiratory rhythm 
generator, which produces basal ventilation when 
chemoreceptors are not stimulated [7].  
The majority of the ventilation control models available in 
literature assume that chemoreceptors act on the respiratory 
system either by directly changing minute ventilation,   , or by 
modifying tidal volume VT and respiratory frequency f, and 
ultimately affecting minute ventilation. In these models, a set of 
static or dynamic equations coupling PaO2 and PaCO2 (or some 
surrogates of these variables) to    (or VT and f) is used to 
describe the whole respiration control system. Hence, the 
physiological link between the controller (i.e. the receptors and 
the respiratory centers in the brain) and the actuator (i.e. the 
respiratory muscles) and the description of lung dynamics are 
missing in these models. The only available model 
incorporating this aspect that we are aware of is the one 
reported in [8], [9]. This model, however, is not suitable for 
integration into our cardiopulmonary model since the input 
quantity to the central chemoreceptors is hydrogen ion 
concentration in the cerebrospinal fluid, which is not a variable 
in our model.  
Hence, we propose a new ventilation control model where 
chemoreceptors act on respiration by modifying the amplitude 
At and the frequency ft of the sinusoidal pressure generator Ut 
(1). Since there is no evidence in the literature of active 
interaction between the two distinct central and peripheral 
chemoreceptor mechanisms, a simple additive relationship 
between central and peripheral responses has been assumed. 
Contributions from the chemoreceptors are then added to the 
basal values from a constant respiratory rhythm generator to 




Fig. 2.  Schematic block diagram of the respiratory control model. At,0 and 
ft,0 are the basal values of amplitude and frequency, whereas       ,       and 
    ,      represent the changes in amplitude and frequency induced by 
central and peripheral chemoreceptor activations, respectively. 
Following the approach in [4], the central chemoreceptor 
mechanism is described as a first-order dynamic system with a 
pure delay, having as input the variation of PCO2 in the arterial 
blood (assuming that variations of PCO2 in arterial blood and in 
the medulla are proportional). Unlike what is assumed in [4], 
outputs of the dynamic system are here the changes in 
amplitude and frequency of the thoracic source: 










    (2)










    (3) 
where, PaCO2,n is the normal value of Pa,CO2 (40 mmHg), gc,A and 
gc,f  are gain factors for the regulatory mechanisms of  At and ft, 
respectively, Dc is the pure delay and finally τc,A and τc,f are time 
constants of the two mechanisms, respectively. 
The description of the peripheral chemoreceptors has been 
modified compared to our previous version of the model in [2]. 
Based on the work in [4], peripheral chemoreflex is described 
as a two-stage transduction mechanism: PaO2 and PaCO2 
variations are first transduced into electrical activity of the 
peripheral chemoreceptor fibers, which are then converted into 
variations of amplitude and frequency of the thoracic source 
generator. As suggested in [4], relationships analogous to those 
in (2) and (3) have been used to describe the second stage: 
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where fapc,n is the basal value of the peripheral chemoreceptor 
activity (i.e. the value computed during normoxia and 
normocapnia), and convention for gains, delay and time 
constants is equivalent to the one adopted in (2) and (3). 
Conversely, the relation describing the first transduction stage 
has been modified from that proposed in [4]. This was 
necessary since the equations proposed in [4] were not able to 
reproduce the overshoot and undershoot characterizing the 
typical peripheral chemoreceptors activity patterns, shown in 
Fig. 3, observed in humans in response to a CO2 step input [10].  
Two different models for afferent peripheral chemorecptors 
activity, reported in [8] and [11], were considered in order to 
replace the equations in [4]. Results proved that only the model 
in [11] was able to reproduce the overshoot and undershoot 
experimentally observed in humans, and for this reason we 
incorporated this model into our peripheral chemoreflex 
description. The block diagram of the model in [11] is shown in 
Fig. 4. 
 
Fig. 3.  Diagrams of time-dependent single-fiber responses of perfused 




Fig. 4.  Block diagram describing the peripheral chemoreceptor model 
(adapted from [11]). Inputs to the model are O2 saturation and CO2 
concentration. Output of the model is the peripheral chemorecptors activity 
fc. Details on individual blocks can be found in [11]. 
III. RESULTS AND DISCUSSION  
In order to illustrate the possibilities offered by the model, 
hypercapnic conditions were simulated and compared to 
published human data. Simulations were performed with the 
cardiopulmonary model in closed-loop configuration and using 
the inspired gas concentrations FICO2 and FIO2 as input. A step 
input from 0% to 7% was used for FICO2, whereas FIO2 was kept 
fixed to its normal room ambient value of 21%. The gains and 
time constants of the peripheral and central chemoreceptors 
where chosen to match the experimental results reported in [1] 
while adhering to physiological constraints. The central and 
peripheral delays were given the values reported in [4]. Based 
on the data in [1], time constants for the breathing frequency 
response were given higher values than the time constants for 
the amplitude response. These time constants for both the 
central and peripheral mechanisms were assumed to have 
different values during the up and down-transient phases. 
Simulation results are shown in Fig. 5 and are compared to 
the experimental data reported in [1]. As we can see, the model 
agrees quite well with the experimental results both in the 
steady-state and transient phases for all the variables under 
study. The most significant level of discrepancy between model 
predictions and experimental data is represented by the 
overshoot in PACO2, which was not observed in the experimental 
data, and by the much more pronounced undershoot in the 
simulated PACO2. This discrepancy, however, could be justified 
by taking into account the averaging of the experimental data, 
since the author of [1] reported that averaging of data over a 
number of subjects tended to smear the undershoot in PACO2 and 
that natural oscillations in partial pressures were observed in 
individual subjects. Moreover, the presence of overshoot and 
undershoot in the predicted PACO2 waveform in response to the 
same kind of CO2 stimulus has been observed in recently 
proposed models ([12], [13]). Further, we could hypothesize 
that the model-predicted overshoot and undershoot responses 
can be ascribed to the absence of a CO2 buffering system, 
otherwise physiologically present in human subjects, which 
would have prevented such drastic changes in PACO2.  
Fig. 6 shows the separate contributions of central and 
peripheral chemoreceptors to the total thoracic source frequency 
and amplitude. As we see, the central chemoreceptors seem to 
play the most important role in triggering the respiratory 
response to hypercapnia. In order to explain this interesting 
phenomenon let us analyze the peripheral chemoreceptors firing 
frequency time pattern. From Fig. 7, at the CO2 stimulus onset 
time, the peripheral chemoreceptor activity initially increases 
rapidly beyond its normal resting value. Beyond this time, these 
receptors are essentially silent during the remaining 7% CO2 
breathing period. The reason for this behavior is essentially due 
to the multiplicative effect of oxygen and carbon dioxide at the 
peripheral chemoreceptors site. Basically, right after the CO2 
stimulus the peripheral chemoreceptors are highly stimulated by 
the increased CO2 level in the arterial blood. This stimulating 
effect of hypercapnia on peripheral chemoreceptors, however, is 
soon counteracted by the progressively increasing O2 level 
(hyperoxia) that is in turn due to the increased minute 
ventilation. As a result, the firing frequency of the peripheral 
chemoreceptors is rapidly reset to values close to those in a 
resting state where they have essentially no effect on triggering 
the respiratory response. 
 
Fig. 5.  Respiratory response to a 7% CO2 step input performed at 2 min and 
lasting 25 min. Continuous lines are model results; dashed lines are 
experimental data redrawn from [1]. Experimental data represents the 
average over 15 subjects. Time continuous model outputs were averaged over 
10 sec in order to follow the same signal processing procedure used in [1]. 
 
In order to check the agreement between model prediction 
and experimental human data at different level of hypercapnic 
stimuli, simulations were also performed at 3%, 5% and 6% 
CO2 step input levels. Fig. 8 compares the steady-state changes 




Fig. 6.  Separate contributions of central (dashed lines) and peripheral 
chemoreceptors (continuous lines) to ΔAt and Δft, the total changes in 
frequency and amplitude of the thoracic source.  
 
Fig. 7.  Peripheral chemoreceptors activity in response to the 7% CO2 step 
input as computed by the model. 
 
Fig. 8.  Steady-state changes for tidal volume, respiratory rate, minute 
ventilation, and alveolar gas partial pressures in response to CO2 step input 
at different levels. Continuous line: model results; dashed line: experimental 
data from [1]. 
 
It shows the correct trending of the respiratory response in 
terms of minute ventilation, tidal volume, respiratory rate and 
alveolar gas partial pressures. The root mean square errors 
(RMSE) in the predicted steady-state changes for each variable 
under study were also computed across the FICO2 range. The 
RMSE is: 5.9 mmHg for PAO2; 1.1 mmHg for PACO2; 2.7 L/min 
for minute ventilation; 1.5 breath/min for respiratory frequency 
and 0.1 L for tidal volume.  
IV. CONCLUSION 
Encouraging results are obtained from our comprehensive 
cardiopulmonary model with normal parameter values, and 
simulation results are compared to experimental human data. 
The predicted respiratory response to different levels of 
hypercapnic stimuli agrees quite well with real human data for 
all the variables under study and in both steady-state and 
transient conditions. The root mean squared errors in the 
predicted steady-state changes are: 5.9 mmHg for PAO2; 1.1 
mmHg for PACO2; 2.7 L/min for minute ventilation; 1.5 
breath/min for respiratory frequency and 0.1 L for tidal volume. 
Our model has feedback regulatory mechanisms for 
chemoreflex, lung stretch, baroreflex, autoregulation and CNS 
ischemic response. These regulate a cardiovascular system 
linked to lung mechanics, gas exchange and metabolic systems. 
Simulating hypercapnic respiratory failure could help in 
understanding COPD, sleep apnea, obesity hypoventilation 
syndrome and other diseases that are prevalent in the ICU. 
Moreover, by altering different parameter values, the model can 
be used to simulate other pathological conditions of clinical 
relevance, such as cardiogenic and hypovolumic shock, 
respiratory obstructions, hypoxia and apnea. Hence, the model 
could be used as a valuable tool to examine cardiopulmonary 
and metabolic changes in ICU patients and run different what if 
scenarios, thus providing useful information for clinical 
decision making. 
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